Skip to main content

Table 1 Laboratory findings on admission

From: Successful use of emapalumab in refractory hemophagocytic lymphohistiocytosis in a child with Chédiak–Higashi syndrome: a case report

Parameter

Status

CBC

White blood cells

4.39 × 109

Red blood cells

3.92 × 1012

Hemoglobin

96 g/L

Hematocrit

0.287 L/L

Platelet

23 × 109/L

Polymorph

7%

Lymphocytes

75%

Monocytes

15%

Liver function test

Total bilirubin

21.9 µmol/L

Direct bilirubin

4 µmol/L

Lactate dehydrogenase

459 U/L

Alanine aminotransferase

84 U/L

Aspartate aminotransferase

277 U/L

Renal function test

Blood urea nitrogen

3.3 mmol/L

Creatinine blood

20 µmol/L

Urinalysis

Glucose

Negative

Protein

Negative

Bilirubin

Negative

Urobilinogen

Negative

 pH

7.5

Ketone

Negative

Blood

Negative

Nitrite

Negative

Leukocytes

Negative

Specific gravity

1.005

Serology

Hepatitis A IgM antibody

Nonreactive

Hepatitis A total antibody

Reactive

Hepatitis B surface antigen

Nonreactive

CMV

Seropositive

EBV

500 IU/mL

Microbiology

Blood culture

Negative

Fungal culture

Negative

PCR

Negative

Chemistry

Ferritin

195 µg/L

Fibrinogen

113 mg/dL

Triglyceride

6.48 mmol/L

Prothrombin time

14.7 seconds

Partial thromboplastin time

44.8 seconds

Potassium

3.9 mmol/L

Sodium

137 mmol/L

Blood glucose random

5.6 mmol/L

Hemoglobin electrophoresis

Normal

Coagulation profile

Normal

  1. CBC complete blood count, CMV cytomegalovirus, EBV Epstein–Barr virus, PCR polymerase chain reaction